Status:
COMPLETED
Inhaled Nitric Oxide by Oxygen Hood in Neonates
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Respiratory Failure
Infant
Eligibility:
All Genders
1-1 years
Phase:
PHASE4
Brief Summary
Inhaled nitric oxide (iNO) improves oxygenation in term infants with respiratory failure. However, iNO has been primarily used in infants receiving mechanical ventilation. This study is a pilot study ...
Detailed Description
Inhaled nitric oxide (iNO) is currently used in the management of ventilated neonates with hypoxemic respiratory failure. We have shown that iNO administered by oxygen hood reduces pulmonary vascular ...
Eligibility Criteria
Inclusion
- gestation \>34 weeks at birth
- age \<7 days
- post-ductal arterial line
- an A-aDO2 of 400 to 600 on two blood gases, at least 30 minutes apart.
Exclusion
- Infants with major malformations
- Infants with cardiac disease
Key Trial Info
Start Date :
March 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00732537
Start Date
March 1 1999
End Date
June 1 2005
Last Update
August 12 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regional Neonatal ICU, University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233